Company Performance Metrics
CleoCare is a women’s health startup focused on breast health, early detection, and personalized risk assessment for breast cancer. The company is developing SenseGlove, a sensor-based wearable paired with an AI-powered mobile application that guides breast self-exams, captures quantitative pressure and motion data, and tracks tissue changes to
build individual baselines over time.
The mobile app provides step-by-step exam guidance, helps ensure full breast coverage, creates personalized risk profiles, and generates actionable reports that can be reviewed by physicians to support clinical decision-making and screening recommendations. CleoCare combines wearable sensing, machine-learning classifiers, and a risk assessment engine designed to support precision prevention and earlier clinical follow-up when meaningful changes are detected.
CleoCare operates under a B2B2C model, initially targeting employers and insurers as a preventive health benefit while building the clinical and health-economic evidence needed to support future reimbursement pathways. The company has completed an FDA pre-submission and is planning and conducting clinical studies, including collaborations with institutions such as the University of Alabama at Birmingham (UAB), as it prepares for U.S. market entry and raises a Seed round.
